High dose rate brachytherapy in the treatment of prostate cancer

World Journal of Urology

Volumn 21, Issue 4, 2003, Pages 220-228

  Vicini, Frank ^a   Vargas, Carlos ^a   Gustafson, Gary ^a   Edmundson, Gregory ^a   Martinez, Alvaro ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

Conformal high dose rate brachytherapy; Radiation therapy; Three dimensional conformal external beam radiotherapy

Indexed keywords

BRACHYTHERAPY; HUMAN; MALE; METHODOLOGY; PROSTATE TUMOR; RADIATION DOSE; REVIEW;

BRACHYTHERAPY; HUMANS; MALE; PROSTATIC NEOPLASMS; RADIATION DOSAGE;

EID: 1542494539     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-003-0358-8     Document Type: Article

References (49)

1. Bolla M, Collette L, Blank L, Warde P, Dubois JB, Mirimanoff RO, Storme G, Bernier J, Kuten A, Sternberg C, Mattelaer J, Lopez TJ, Pfeffer JR, Lino CC, Zurlo A, Pierart M (2002) Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial. Lancet 360:103-106
2. Bolla M, Gonzalez D, Warde P, Dubois JB, Mirimanoff RO, Storme G, Bernier J, Kuten A, Sternberg C, Gil T, Collette L, Pierart M (1997) Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. N Engl J Med 337:295-300
3. Borghede G, Hedelin H, Holmang S, Johansson KA, Aldenborg F, Pettersson S, Sernbo G, Wallgren A, Mercke C (1997) Combined treatment with temporary short-term high dose rate iridium-192 brachytherapy and external beam radiotherapy for irradiation of localized prostatic carcinoma. Radiother Oncol 44:237-244
4. Borghede G, Hedelin H, Holmang S, Johansson KA, Sernbo G, Mercke C (1997) Irradiation of localized prostatic carcinoma with a combination of high dose rate iridium-192 brachytherapy and external beam radiotherapy with three target definitions and dose levels inside the prostate gland. Radiother Oncol 44:245-250
5. Brenner DJ, Martinez AA, Edmundson GK, Mitchell C, Thames HD, Armour EP (2002) Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha/beta ratio), similar to late-responding normal tissue. Int J Radiat Oncol Biol Phys 52:6-13
6. Curran MJ, Healey GA, Bihrle W, III, Goodman N, Roth RA (2000) Treatment of high-grade low-stage prostate cancer by high-dose-rate brachytherapy. J Endourol 14:351-356
7. D'Souza WD, Thames HD (2001) Is the alpha/beta ratio for prostate cancer low? Int J Radiat Oncol Biol Phys 51:1-3
8. Deger S, Boehmer D, Turk I, Roigas J, Wernecke KD, Wiegel T, Hinkelbein W, Dinges S, Budach V, Loening SA (2002) High dose rate brachytherapy of localized prostate cancer. Eur Urol 41:420-426
9. Deger S, Dinges S, Roigas J, Schnorr D, Turk I, Budach V, Hinkelbein W, Loening SA (1997) High-dose rate iridium192 afterloading therapy in combination with external beam irradiation for localized prostate cancer. Tech Urol 3:190-194
10. Demanes DJ, Rodriguez RR, Altieri GA (2000) High dose rate prostate brachytherapy: the California Endocurietherapy (CET) method. Radiothcr Oncol 57:289-296
11. Duchesne GM, Peters LJ (1999) What is the alpha/beta ratio for prostate cancer? Rationale for hypofractionated high-doserate brachytherapy. Int J Radiat Oncol Biol Phys 44:747-748
12. Edmundson GK, Van D, Martinez AA (1995) Intraoperative optimization of needle placement and dwell times for conformal prostate brachytherapy. Int J Radiat Oncol Biol Phys 33:1257-1263
13. Fivcash JB, Hanks G, Roach M, Wang S, Vigneault E, McLaughlin PW, Sandler HM (2000) 3D conformal radiation therapy (3DCRT) for high grade prostate cancer: a multiinstitutional review. Int J Radiat Oncol Biol Phys 47:335-342
14. Forman JD, Porter AT (1997) The experience with neutron irradiation in locally advanced adenocarcinoma of the prostate. Semin Urol Oncol 15:239-243
15. Fowler J, Chappell R, Ritter M (2001) Is alpha/beta for prostate tumors really low? Int J Radiat Oncol Biol Phys 50:1021-1031
16. Fowler JF, Chappell RJ, Ritter MA (2002) The prospects for new treatments for prostate cancer. Int J Radiat Oncol Biol Phys 52:3-5
17. Fukunaea-Johnson N, Sandler HM, McLauchlin PW, Strawderman MS, Grijalva KH, Kish KE, Lichter AS (1997) Results of 3D conformal radiotherapy in the treatment of localized prostate cancer. Int J Radiat Oncol Biol Phys 38:311-317
18. Galalae RM, Kovacs G, Schultze J, Loch T, Rzehak P, Wilhelm R, Bertermann H, Buschbcck B, Kohr P, Kimmig B (2002) Long-term outcome after elective irradiation of the pelvic lymphatics and local dose escalation using high-dose-rate brachytherapy for locally advanced prostate cancer. Int J Radiat Oncol Biol Phys 52:81-90
19. Gerber GS, Thisted RA, Chodak GW, Schroder FH, Frohmuller HG, Scardino PT, Paulson DF, Middleton AW, Jr., Rukstalis DB, Smith JA, Jr., Ohori M, Theiss M, Schellhammer PF (1997) Results of radical prostatectomy in men with locally advanced prostate cancer: multi-institutional pooled analysis. Eur Urol 32:385-390
20. Han M, Partin AW, Pound CR, Epstein JI, Walsh PC (2001) Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience. Urol Clin North Am 28:555-565
21. Hanks GE (2000) Conformal radiotherapy for prostate cancer. Ann Med 32:57-63
22. Hanks GE, Hanlon AL, Pinover WH, Honvitz EM, Price RA, Schultheiss T (2000) Dose selection for prostate cancer patients based on dose comparison and dose response studies. Int J Radiat Oncol Biol Phys 46:823-832
23. Hanks GE, Hanlon AL, Pinover WH, Horwitz EM, Schultheiss TE (1999) Survival advantage for prostate cancer patients treated with high-dose three-dimensional conformal radiotherapy. Cancer J Sci Am 5:152-158
24. Hanks GE, Hanlon AL, Schultheiss TE, Pinover WH, Movsas B, Epstein BE, Hunt MA (1998) Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization, and future directions. Int J Radiat Oncol Biol Phys 41:501-510
25. Kestin LL, Martinez AA, Stromberg JS, Edmundson GK, Gustafson GS, Brabbins DS, Chen PY, Vicini FA (2000) Matched-pair analysis of conformal high-dose-rate brachytherapy boost versus external-beam radiation therapy alone for locally advanced prostate cancer. J Clin Oncol 18:2869-2880
26. Kini VR, Edmundson GK, Vicini FA, Jafiray DA, Gustafson G, Martinez AA (1999) Use of three-dimensional radiation therapy planning tools and intraoperative ultrasound to evaluate high dose rate prostate brachytherapy implants. Int J Radiat Oncol Biol Phys 43:571-578
27. Lattanzi J, McNeeley S, Donnelly S, Palacio E, Hanlon A, Schultheiss TE, Hanks GE (2000) Ultrasound-based stereotactic guidance in prostate cancer-quantification of organ motion and set-up errors in external beam radiation therapy. Comput Aided Surg 5:289-295
28. Martinez A, Gonzalez J, Spencer W, Gustafson G, Kestin L, Kearney D, Vicini FA (2003) Conformal high dose rate brachytherapy improves biochemical control and cause specific survival in patients with prostate cancer and poor prognostic factors. J Urol 169:974-979
29. Martinez AA, Gustafson G, Gonzalez J, Armour E, Mitchell C, Edmundson G, Spencer W, Stromberg J, Huang R, Vicini F (2002) Dose escalation using conformal high-dose-rate brachytherapy improves outcome in unfavorable prostate cancer. Int J Radiat Oncol Biol Phys 53:316-327
30. Martinez AA, Kestin LL, Stromberg JS, Gonzalez JA, Wallace M, Gustafson GS, Edmundson GK, Spencer W, Vicini FA (2000) Interim report of image-guided conformal high-dose-rate brachytherapy for patients with unfavorable prostate cancer: the William Beaumont phase II dose-escalating trial. Int J Radiat Oncol Biol Phys 47:343-352
31. Martinez AA, Pataki I, Edmundson G, Sebastian E, Brabbins D, Gustafson G (2001) Phase II prospective study of the use of conformal high-dose-rate brachytherapy as monotherapy for the treatment of favorable stage prostate cancer: a feasibility report. Int J Radiat Oncol Biol Phys 49:61-69
32. Mate TP, Gottesman JE, Hatton J, Gribble M, Van Hollebeke L (1998) High dose-rate afterloading 192Iridium prostate brachytherapy: feasibility report. Int J Radiat Oncol Biol Phys 41:525-533
33. Michalski JM, Purdy JA, Winter K, Roach M, III, Vijayakumar S, Sandler HM, Markoe AM, Ritter MA, Russell KJ, Sailer S, Harms WB, Perez CA, Wilder RB, Hanks GE, Cox JD (2000) Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406. Int J Radiat Oncol Biol Phys 46:391-402
34. Nag S, Gupta N (2000) A simple method of obtaining equivalent doses for use in HDR brachytherapy. Int J Radiat Oncol Biol Phys 46:507-513
35. Oefelein MG, Smith ND, Grayhack JT, Schaeffer AJ, McVary KT (1997) Long-term results of radical retropubic prostatectomy in men with high grade carcinoma of the prostate. J Urol 158:1460-1465
36. Paul R, Hofmann R, Schwarzer JU, Stepan R, Feldmann HJ, Kneschaurek P, Molls M, Hartung R (1997) Iridium 192 high-dose-rate brachytherapy - a useful alternative therapy for localized prostate cancer? World J Urol 15:252-256
37. Pellizzon AC, Nadalin W, Salvajoli JV, Fogaroli RC, Novaes PE, Maia MA, Ferrigno R (2003) Results of high dose rate afterloading brachytherapy boost to conventional external beam radiation therapy for initial and locally advanced prostate cancer. Radiother Oncol 66:167-172
38. Pilepich MV, Caplan R, Byhardt RW, Lawton CA, Gallagher MJ, Mesic JB, Hanks GE, Coughlin CT, Porter A, Shipley WU, Grignon D (1997) Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85-31. J Clin Oncol 15:1013-1021
39. Pollack A, Zagars GK, Smith LG, Lee JJ, von Eschenbach AC, Antolak JA, Starkschall G, Rosen I (2000) Preliminary results of a randomized radiotherapy dose-escalation study comparing 70 Gy with 78 Gy for prostate cancer. J Clin Oncol 18:3904-3911
40. Pollack A, Zagars GK, Starkschall G, Antolak JA, Lee JJ, Huang E, von Eschenbach AC, Kuban DA, Rosen I (2002) Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys 53:1097-1105
41. Ragde H, Elgamal AA, Snow PB, Brandt J, Bartolucci AA, Nadir BS, Korb LJ (1998) Ten-year disease free survival after transpcrineal sonography-guided iodine-125 brachytherapy with or without 45-gray external beam irradiation in the treatment of patients with clinically localized, low to high Gleason grade prostate carcinoma [see comments]. Cancer 83:989-1001
42. Stromberg JS, Martinez AA, Horwitz EM, Gustafson GS, Gonzalez JA, Spencer WF, Brabbins DS, Dmuchowski CF, Hollander JB, Vicini FA (1997) Conformal high dose rate iridium-192 boost brachytherapy in locally advanced prostate cancer: superior prostate-specific antigen response compared with external beam treatment. Cancer J Sci Am 3:346-352
43. Syed AM, Puthawala A, Sharma A, Gamie S, Londrc A, Cherlow JM, Damore SJ, Nazmy N, Sheikh KM, Ko SJ (2001) High-dose-rate brachytherapy in the treatment of carcinoma of the prostate. Cancer Control 8:511-521
44. Vicini FA, Abner A, Baglan KL, Kestin LL, Martinez AA (2001) Defining a dose-response relationship with radiotherapy for prostate cancer: is more really better? Int J Radiat Oncol Biol Phys 51:1200-1208
45. Vicini FA, Kestin LL, Martinez AA (2000) Use of conformal high-dose rate brachytherapy for management of patients with prostate cancer: optimizing dose escalation. Tech Urol 6:135-145
46. Yan D, Lockman D (2001) Organ/patient geometric variation in external beam radiotherapy and its effects. Med Phys 28:593-602
47. Yan D, Xu B, Lockman D, Kota K, Brabbins DS, Wong J, Martinez AA (2001) The influence of interpatient and intra-patient rectum variation on external beam treatment of prostate cancer. Int J Radiat Oncol Biol Phys 51:1111-1119
48. Yoshioka Y, Nose T, Yoshida K, Inoue T, Yamazaki H, Tanaka E, Shiomi H, Imai A, Nakamura S, Shimamoto S, Inoue T (2000) High-dose-rate interstitial brachytherapy as a monotherapy for localized prostate cancer: treatment description and preliminary results of a phase I/II clinical trial. Int J Radiat Oncol Biol Phys 48:675-681
49. Yoshioka Y, Nose T, Yoshida K, Oh RJ, Yamada Y, Tanaka E, Yamazaki H, Inoue T, Inoue T (2003) High-dose-rate brachytherapy as monotherapy for localized prostate cancer: a retrospective analysis with special focus on tolerance and chronic toxicity. Int J Radiat Oncol Biol Phys 56:213-220